Pronostic et objectifs thérapeutiques du diabète de l'enfant

Revue du Praticien

Volumn 46, Issue 5, 1996, Pages 570-575

  Bougnères, Pierre ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; CHILD; DIABETES CONTROL; DIABETIC RETINOPATHY; DIET; DISEASE COURSE; DRUG USE; HUMAN; INCIDENCE; JUVENILE DIABETES MELLITUS; PATIENT CARE; PROGNOSIS; REVIEW; BLOOD; CHEMICALLY INDUCED DISORDER; DIET THERAPY; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MOTIVATION;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; GOALS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; PROGNOSIS;

EID: 0029875938     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Merimee T. Diabetic retinopathy: a synthesis of perspectives. N Engl J Med 1990; 332: 978-83.
2. Marre M, Bernadet P, Gallois Y et al. Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complication. Diabetes 1994; 43: 384-8.
3. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43: 690-5.
4. Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to etiology of type I diabetes mellitus and its complications. N Engl J Med 1987; 317: 1390-8.
5. Kador PF. The role of aldose reductase in the development of diabetic complications. Med Res Rev 1988; 8: 325-52.
6. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-21.
7. Raskin P, Rosenstock J. Aldose reductase inhibitors and diabetic complications. Am J Med 1987; 83: 298-306.
8. Brownlee M. Glycation and diabetic complications. Diabetes 1994; 43: 836-41.
9. Schmidt AM et al. Receptor for advanced glycation and products (AGES) has a central role invested wall interactions and gene activation in response to circulation AGE proteins. Proc Natl Acad Sci USA 1994; 91: 8807-11.
10. Baynes JW. AGEing growth factors: a role in diabetic vascular disease. J Clin Invest 1988; 2: 2-3.
11. Giordano I, Edelstein D, Browlee M. Non enzymatic giycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity A model for intracellular glycolysation in diabetes. J Clin Invest 1994; 94: 110-7.
12. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 1991; 40: 1328-34.
13. Edelstein D, Brownlee M. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 1992; 41: 26-9.
14. White P. Natural course and prognosis of juvenile diabetes. Diabetes 1956; 5: 445-50.
15. Paz-Guevara AT. Juvenile diabetes mellitus after forty years. Diabetes 1975; 24: 559-65.
16. Pirart J. Diabète et complications dégénératives. Présentation d'une étude prospective portant sur 4 400 cas observés entre 1947 et 1973. Diabete Metab 1977; 3: 97-107 et 173-182 et 245-56.
17. Wang PH. Meta-analysis of effects of intensive blood-glucose control on late complications in type I diabetes. Lancet 1993; 341: 1306-9.
18. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-9.
19. Brichmann-Hansen O. Blood glucose concentrations and progression of diabetic retinopathy: the seven year result of the Oslo study. B M J 1992; 304: 19-22.
20. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
21. Warram JH, Manson JE, Krolewski AS. Glycated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl J Med 1998; 332: 1305-6.
22. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1251-5.
23. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes control and complications trial. J Pediatr 1994; 125: 177-88.
24. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993; 328: 1676-85.
25. Bougnères P, Landais P, Mairesse AM et al. Improvement of diabetic control and acceptability of a three-injection insulin regimen in diabetic adolescents. Diabetes Care 1993; 16: 94-102.
26. Rosenbloom AL. Diabetes control and adolescents. Diabetes Care 1985; 8: 304.
27. Mullis P, Volkle H, Sigrist et al. Comparison of fructosamine and glycated haemoglobin in children with type I (insulin-dependent) diabetes mellitus. Diabetologia 1988; 31: 351-4.
28. Daneman D, Tsalikian E, Hengstenberg F et al. Glycosylated haemoglobin in children with insulin-dependent diabetes mellitus. Diabetologia 1980; 19: 423-6.
29. Goldstein DE, Walker B, Rawlings SS. Hemoglobin A l c levels in children and adolescents with diabetes mellitus. Diabetes Care 1980; 3: 503-7.
30. Dahlqvist G, Blom L, Bolme P et al. Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA l c: relation to age, duration, C peptide, insulin dose and one or two insulin injections. Diabetes Care 1982; 5: 399-403.
31. Belmonte MM, Schiffrin A, Dufresne J et al. Impact of SMBG on control of diabetes as measured by HbA l c: 3-yr survey of a juvenile IDDM clinic. Diabetes Care 1988; 11: 484-8.
32. Kaar ML, Akerblom HK, Huttenen NP, Knip M, Sakkinen K. Metabolic control in children and adolescents with insulin dependent diabetes mellitus. Acta Paediatr Scand 1984; 73: 102-8.
33. Tubiana-Rufi N, Moret L, Chwalow J et al. État de santé et facteurs liés au contrôle glycémique chez 165 enfants atteints de diabète insuline-dépendant âgés de 7 à 13 ans. Arch Pediatr 1994; 1: 982-90.
34. Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992; 15: 1875-91.
35. Bojestig M, Arnqvist HJ, Hermansson G, Kartberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994; 330: 15-8.
36. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type I diabetes. Am J Med 1985; 78: 786-94.
37. Geffner ME. Reviewing the Diabetes Control and Complications Trial: one member of the "control panel" speaks. J Pediatr 1994; 125: 228-9.